BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26474948)

  • 1. Brown spider (Loxosceles genus) venom toxins: Evaluation of biological conservation by immune cross-reactivity.
    Buch DR; Souza FN; Meissner GO; Morgon AM; Gremski LH; Ferrer VP; Trevisan-Silva D; Matsubara FH; Boia-Ferreira M; Sade YB; Chaves-Moreira D; Gremski W; Veiga SS; Chaim OM; Senff-Ribeiro A
    Toxicon; 2015 Dec; 108():154-66. PubMed ID: 26474948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the understanding of brown spider venoms: From the biology of spiders to the molecular mechanisms of toxins.
    Gremski LH; Trevisan-Silva D; Ferrer VP; Matsubara FH; Meissner GO; Wille AC; Vuitika L; Dias-Lopes C; Ullah A; de Moraes FR; Chávez-Olórtegui C; Barbaro KC; Murakami MT; Arni RK; Senff-Ribeiro A; Chaim OM; Veiga SS
    Toxicon; 2014 Jun; 83():91-120. PubMed ID: 24631373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astacin-like metalloproteases are a gene family of toxins present in the venom of different species of the brown spider (genus Loxosceles).
    Trevisan-Silva D; Gremski LH; Chaim OM; da Silveira RB; Meissner GO; Mangili OC; Barbaro KC; Gremski W; Veiga SS; Senff-Ribeiro A
    Biochimie; 2010 Jan; 92(1):21-32. PubMed ID: 19879318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered antigen containing epitopes from Loxosceles spp. spider toxins induces a monoclonal antibody (Lox-mAb3) against astacin-like metalloproteases.
    Costa TGF; Costal-Oliveira F; de Assis TCS; Lima SA; Martins CA; Finco AB; Veiga SS; Soccol VT; Machado-de-Ávila RA; Figueiredo LFM; Minozzo JC; Kalapothakis E; Guerra-Duarte C; Alvarenga LM; Chávez-Olórtegui C
    Int J Biol Macromol; 2020 Nov; 162():490-500. PubMed ID: 32574737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
    Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
    Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and immunological cross-reactivity of LALP3, a novel astacin-like metalloprotease from brown spider (Loxosceles intermedia) venom.
    Morgon AM; Belisario-Ferrari MR; Trevisan-Silva D; Meissner GO; Vuitika L; Marin B; Tashima AK; Gremski LH; Gremski W; Senff-Ribeiro A; Veiga SS; Chaim OM
    Biochimie; 2016; 128-129():8-19. PubMed ID: 27343628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brown spiders and loxoscelism.
    da Silva PH; da Silveira RB; Appel MH; Mangili OC; Gremski W; Veiga SS
    Toxicon; 2004 Dec; 44(7):693-709. PubMed ID: 15500846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential metalloprotease content and activity of three Loxosceles spider venoms revealed using two-dimensional electrophoresis approaches.
    Trevisan-Silva D; Bednaski AV; Gremski LH; Chaim OM; Veiga SS; Senff-Ribeiro A
    Toxicon; 2013 Dec; 76():11-22. PubMed ID: 24018360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
    Guilherme P; Fernandes I; Barbaro KC
    Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ICK peptide from the Loxosceles intermedia (brown spider) venom gland: cloning, heterologous expression and immunological cross-reactivity approaches.
    Matsubara FH; Gremski LH; Meissner GO; Constantino Lopes ES; Gremski W; Senff-Ribeiro A; Chaim OM; Veiga SS
    Toxicon; 2013 Sep; 71():147-58. PubMed ID: 23751278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a common epitope in knottins and phospholipases D present in Loxosceles sp venom by a monoclonal antibody.
    Alves-Mondini C; Beltramino M; Jiacomini IG; Karim-Silva S; Dos Santos Antunes N; de Moura J; Aubrey N; Billiald P; Machado-de-Ávila RA; Alvarenga LM; Becker-Finco A
    Int J Biol Macromol; 2023 Aug; 246():125588. PubMed ID: 37399872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Protein Containing B-Cell Epitopes of Different
    Lima SA; Guerra-Duarte C; Costal-Oliveira F; Mendes TM; Figueiredo LFM; Oliveira D; Machado de Avila RA; Ferrer VP; Trevisan-Silva D; Veiga SS; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
    Front Immunol; 2018; 9():653. PubMed ID: 29666624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
    de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
    Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotechnological applications of brown spider (Loxosceles genus) venom toxins.
    Senff-Ribeiro A; Henrique da Silva P; Chaim OM; Gremski LH; Paludo KS; Bertoni da Silveira R; Gremski W; Mangili OC; Veiga SS
    Biotechnol Adv; 2008; 26(3):210-8. PubMed ID: 18207690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic cross-reactivity of venoms from medically important Loxosceles (Araneae) species in Brazil.
    Barbaro KC; Eickstedt VR; Mota I
    Toxicon; 1994 Jan; 32(1):113-20. PubMed ID: 9237343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
    de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
    Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms.
    Dias-Lopes C; Felicori L; Rubrecht L; Cobo S; Molina L; Nguyen C; Galéa P; Granier C; Molina F; Chávez-Olortegui C
    Vaccine; 2014 Apr; 32(18):2086-92. PubMed ID: 24565754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).
    Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS
    Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
    Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
    Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
    de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
    Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.